BUSINESS● LOW12h ago · Oct 14, 2026, 9:14 PM
Lakefront sells early-stage CAR-T programs to Armed Cell Therapeutics
Seeking Alpha Tech · global
Lakefront has sold its early-stage CAR-T programs to Armed Cell Therapeutics, indicating a transaction involving biotech assets. This news is relevant to the pharmaceutical and investment communities.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS20m agoWho Is Competing to Connect America?AEIBUSINESS22m agoTSMC confirms talks with Elon Musk over Texas ‘Terafab’ but insists on operational controlSouth China Morning Post